Identification of High-Risk Chronic Heart Failure Patients in Clinical Practice: Role of Changes in Left Ventricular Function

被引:6
作者
Cicoira, Mariantonietta [1 ]
Rossi, Andrea [1 ]
Chiampan, Andrea [1 ]
Frigo, Giulia [1 ]
Bergamini, Corinna [1 ]
Rigolli, Marzia [1 ]
Zanolla, Luisa [1 ]
Vassanelli, Corrado [1 ]
机构
[1] Univ Verona, Dept Med, Cardiol Sect, I-37100 Verona, Italy
关键词
EJECTION FRACTION; LONG-TERM; MYOCARDIAL-INFARCTION; DYSFUNCTION; SPIRONOLACTONE; MORTALITY; SURVIVAL; IMPROVEMENT; PREDICTORS; METOPROLOL;
D O I
10.1002/clc.22024
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Left ventricular (LV) dysfunction and remodeling are key pathophysiological features underlying disease progression in chronic heart failure (CHF). Hypothesis: To describe the course of LV dysfunction and identify predictors and prognostic impact of changes in LV volumes and function in stable CHF patients under optimal therapy. Methods: There were 318 consecutive CHF outpatients who underwent a repeated echocardiographic evaluation at baseline and at 1 year and subsequently followed-up for at least 12 months. The end point of the study was all-cause mortality. Results: Mean LV ejection fraction (LVEF) was 33 +/- 7% at baseline and 36 +/- 9% at follow-up. Twenty-four percent of patients had an improvement of LVEF >5 absolute points (group 1); 58% remained stable (group 2), 17% worsened at >5 absolute points (group 3). Age, New York Heart Association class, diuretic dose, renal function, and baseline LVEF were independent predictors of LVEF improvement at 1 year. At the Cox analysis, patients in group 3 had a 4-fold higher risk of death when compared with group 1 (hazard ratio: 3.99, 95% confidence interval: 1.6-9.9, P = 0.002), independently of age, etiology, and symptoms severity. Conclusions: In stable CHF outpatients, LV function improves in 24% of cases; a modest decrease in LV systolic function is associated with a significantly higher risk of all-cause mortality, independent of other markers of disease severity. Clin. Cardiol. 2012 doi: 10.1002/clc.22024 The authors have no funding, financial relationships, or conflicts of interest to disclose.
引用
收藏
页码:580 / 584
页数:5
相关论文
共 28 条
[1]   Left ventricular dysfunction: causes, natural history, and hopes for reversal [J].
Armstrong, P .
HEART, 2000, 84 :I15-I17
[2]   Effects of ACE gene insertion/deletion polymorphism on response to spironolactone in patients with chronic heart failure [J].
Cicoira, M ;
Rossi, A ;
Bonapace, S ;
Zanolla, L ;
Perrot, A ;
Francis, DP ;
Golia, G ;
Franceschini, L ;
Osterziel, KJ ;
Zardini, P .
AMERICAN JOURNAL OF MEDICINE, 2004, 116 (10) :657-661
[3]   Long-term, dose-dependent effects of spironolactone on left ventricular function and exercise tolerance in patients with chronic heart failure [J].
Cicoira, M ;
Zanolla, L ;
Rossi, A ;
Golia, G ;
Franceschini, L ;
Brighetti, G ;
Marino, P ;
Zardini, P .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (02) :304-310
[4]   A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure [J].
Cohn, JN ;
Tognoni, G .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (23) :1667-1675
[5]  
COHN JN, 1993, CIRCULATION, V87, P5
[6]   Metoprolol reverses left ventricular remodeling in patients with asymptomatic systolic dysfunction - The Reversal of ventricular remodeling with Toprol-XL (REVERT) trial [J].
Colucci, Wilson S. ;
Kolias, Theodore J. ;
Adams, Kirkwood F. ;
Armstrong, William F. ;
Ghali, Jalal K. ;
Gottlieb, Stephen S. ;
Greenberg, Barry ;
Klibaner, Michael I. ;
Kukin, Marrick L. ;
Sugg, Jennifer E. .
CIRCULATION, 2007, 116 (01) :49-56
[7]   Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial [J].
Dargie, HJ ;
Colucci, Y ;
Ford, I ;
Sendon, JLL ;
Remme, W ;
Sharpe, N ;
Blank, A ;
Holcslaw, TL .
LANCET, 2001, 357 (9266) :1385-1390
[8]   The effects of β-blockers in patients with stable chronic heart failure.: Predictors of left ventricular ejection fraction improvement and impact on prognosis [J].
de Groote, Pascal ;
Delour, Pierre ;
Mouquet, Frederic ;
Lamblin, Nicolas ;
Dagorn, Joeel ;
Hennebert, Olivier ;
Le Tourneau, Thierry ;
Foucher-Hossein, Claude ;
Verkindere, Christine ;
Bauters, Christophe .
AMERICAN HEART JOURNAL, 2007, 154 (03) :589-595
[9]   LEFT-VENTRICULAR SHAPE, AFTERLOAD AND SURVIVAL IN IDIOPATHIC DILATED CARDIOMYOPATHY [J].
DOUGLAS, PS ;
MORROW, R ;
IOLI, A ;
REICHEK, N .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1989, 13 (02) :311-315
[10]   EFFECTS OF LONG-TERM ENALAPRIL THERAPY ON CARDIAC STRUCTURE AND FUNCTION IN PATIENTS WITH LEFT-VENTRICULAR DYSFUNCTION - RESULTS OF THE SOLVD ECHOCARDIOGRAPHY SUBSTUDY [J].
GREENBERG, B ;
QUINONES, MA ;
KOILPILLAI, C ;
LIMACHER, M ;
SHINDLER, D ;
BENEDICT, C ;
SHELTON, B .
CIRCULATION, 1995, 91 (10) :2573-2581